MicroRNA-130a regulates chondrocyte proliferation and alleviates osteoarthritis through PTEN/PI3K/Akt signaling pathway
Related Experiment Video
Updated: Feb 13, 2026

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
Published on: August 23, 2024
Yun Zhang1, Shaochen Xu1, Eric Huang1
1Department of Orthopaedics, Shanghai Tongji Hospital, Shanghai 200065, P.R. China.
Abstract:
The function of microRNA‑130a in development and progression of osteoarthritis was determined. In osteoarthritis patients, the serum levels of microRNA‑130a were decreased, compared with normal group. Overexpression of microRNA‑130a increased cell proliferation and decreased apoptosis of chondrocytes, and downregulation of microRNA‑130a also decreased cell proliferation and induced apoptosis in chondrocytes. Downregulation of microRNA‑130a promoted Bax and caspase‑3/9 protein expression, increased inflammation divisors and suppressed the PTEN/PI3K/Akt signaling pathway. PTEN inhibitor, VO‑Ohpic trihydrate increased the destructive effect of microRNA‑130a on cell proliferation of chondrocytes. PI3K inhibitor, wortmannin also increased the destructive effect of microRNA‑130a on osteoarthritis. In conclusion, microRNA‑130a is an important regulator of osteoarthritis in chondrocytes through PTEN/PI3K/Akt signaling pathway.
Insights
MicroRNA-130a levels decrease in osteoarthritis patients. This microRNA regulates chondrocyte proliferation and apoptosis via the PTEN/PI3K/Akt pathway, impacting osteoarthritis progression.
Area of Science:
- Biochemistry
- Molecular Biology
- Cell Biology
Background:
- Osteoarthritis (OA) is a degenerative joint disease characterized by cartilage breakdown.
- MicroRNAs (miRNAs) play crucial roles in cellular processes and disease development.
- The specific role of microRNA-130a in OA pathogenesis requires further elucidation.
Purpose of the Study:
- To investigate the function of microRNA-130a in the development and progression of osteoarthritis.
- To explore the underlying molecular mechanisms involving the PTEN/PI3K/Akt signaling pathway.
Main Methods:
- Serum levels of microRNA-130a were measured in OA patients and healthy controls.
- Chondrocyte proliferation and apoptosis were assessed following microRNA-130a manipulation (overexpression and downregulation).
- Protein expression of Bax, caspase-3/9, and the PTEN/PI3K/Akt pathway components were analyzed.
- The effects of PTEN and PI3K inhibitors on chondrocyte behavior were evaluated.
Main Results:
- Serum levels of microRNA-130a were significantly decreased in osteoarthritis patients compared to the normal group.
- Overexpression of microRNA-130a promoted chondrocyte proliferation and inhibited apoptosis.
- Downregulation of microRNA-130a decreased chondrocyte proliferation, induced apoptosis, increased Bax and caspase-3/9 expression, elevated inflammation markers, and suppressed the PTEN/PI3K/Akt pathway.
- PTEN and PI3K inhibitors exacerbated the detrimental effects of microRNA-130a downregulation on chondrocytes.
Conclusions:
- MicroRNA-130a acts as a critical regulator in osteoarthritis development within chondrocytes.
- The PTEN/PI3K/Akt signaling pathway is a key mediator of microRNA-130a's function in osteoarthritis.
- MicroRNA-130a represents a potential therapeutic target for osteoarthritis treatment.
Related Concept Videos
PI3K/mTOR/AKT Signaling Pathway
MicroRNAs
Notch Signaling Pathway
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
Hedgehog Signaling Pathway
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Non-Canonical Wnt Signaling Pathways

